Miller Richard A MD

CIK 0001031847

President and CEODirector

Filings

Latest May 20, 2026

Issuers covered

Showing

15 of 15

Page 1

Track record

9 of 11 open-market trades scored (82% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	9	56%	-0.3%	+5.9%	+16.2%	-17.3%
90 days	9	11%	-13.6%	-10.8%	+47.6%	-38.9%
180 days	9	11%	+20.5%	-8.9%	+372.3%	-56.9%
365 days	9	67%	+94.6%	+102.8%	+238.2%	-54.6%

Issuers

Companies where Miller Richard A MD has filed

Ticker	Issuer	Filings	Last filed
CRVS	Corvus Pharmaceuticals, Inc.	12	May 20, 2026
BOLT	Bolt Biotherapeutics, Inc.	3	Jun 14, 2023

All filings

15 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 20, 2026	CRVSCorvus Pharmaceuticals, Inc.	PPurchase	5,000	$12.05	$60,250
Dec 8, 2025	CRVSCorvus Pharmaceuticals, Inc.	Holdings only	-	-	-
May 9, 2025	CRVSCorvus Pharmaceuticals, Inc.	MExercise	559,073	$3.50	$1,956,756
Dec 23, 2024	CRVSCorvus Pharmaceuticals, Inc.	Holdings only	-	-	-
May 14, 2024	CRVSCorvus Pharmaceuticals, Inc.	GGift	302,016	$0.00	$0
May 7, 2024	CRVSCorvus Pharmaceuticals, Inc.	PPurchase	577,634	$1.7312	$1,000,000
Dec 8, 2023	CRVSCorvus Pharmaceuticals, Inc.	Holdings only	-	-	-
Jun 14, 2023	BOLTBolt Biotherapeutics, Inc.	Holdings only	-	-	-
Apr 3, 2023	CRVSCorvus Pharmaceuticals, Inc.	Holdings only	-	-	-
Jun 28, 2022	CRVSCorvus Pharmaceuticals, Inc.	PPurchase	5,000	$1.03	$5,150
Jun 10, 2022	BOLTBolt Biotherapeutics, Inc.	Holdings only	-	-	-
Jun 6, 2022	CRVSCorvus Pharmaceuticals, Inc.	PPurchase	4,830	$0.98	$4,733
Apr 1, 2022	CRVSCorvus Pharmaceuticals, Inc.	PPurchase	15,000	$1.6356	$24,534
Mar 28, 2022	BOLTBolt Biotherapeutics, Inc.	Holdings only	-	-	-
Mar 17, 2022	CRVSCorvus Pharmaceuticals, Inc.	PPurchase	25,000	$1.466	$36,650

Showing 1-15 of 15

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value